Simple Summary Growing evidence indicates that blood-count-based compound scores
could be used as prognostic biomarkers in cancer as reflectors of uncontrolled inflammation …

Advances in hematopoietic cell transplantation (HCT) technology and supportive care
techniques have led to improvements in long-term survival after HCT. Emerging indications …

Background We evaluated the overall and site-specific incidence of cancer in subjects with
primary immunodeficiency diseases (PIDD) enrolled in the United States Immune Deficiency …

The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT)
survivors continues to increase. Among patients whose disease remains in remission for the …

Second and higher-order malignancies now comprise about 18% of all incident cancers in
the USA, superseding first primary cancers of the breast, lung, and prostate. The occurrence …

Hematopoietic cell transplantation (HCT) is an important curative treatment for children with
high-risk hematologic malignancies, solid tumors, and, increasingly, nonmalignant diseases …

The risk of cervical cancer (CC) among women immunosuppressed for a variety of reasons
is well documented in the literature. Although there is improved organ function, quality of life …

Cyclophosphamide combined with total body irradiation (Cy/TBI) or busulfan (BuCy) are the
most widely used myeloablative conditioning regimens for allotransplants. Recent data …

Background The number of long-term survivors after hematopoietic stem cell transplantation
(HSCT) showed steady increase in the past two decades. Second malignancies after HSCT …

With continuing improvements in the successful treatment of pediatric malignancies, long
term survivors of pediatric cancers and their providers are faced with new oncologic issues …